Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway

Abstract

Suramin administration represents a novel and effectively therapeutic approach, which could potentially alleviate IDD by reducing extracellular matrix (ECM) deposition and inhibiting apoptosis and inflammatory responses in the NP cells. Cite this article: <i>Bone Joint Res</i> 2021;10(8):498-513.